11:28:46Philippines

MaxCyte, Inc. (MXCT)

NASDAQ

Key stats Fiscal year 2025

Income statement

Revenue
33,026,000 -14.5%
Net income
-44,630,000
Gross profit
26,804,000
Operating income
-51,897,000
Earnings per share
-0.42
R&D expense
20,823,000

Growth and profitability

Gross margin
81.16
Operating margin
-157.14
Net margin
-135.14
Return on equity
-26.02
Return on assets
-22.04
Free cash flow margin
-109.54

Balance sheet

Total assets
202,507,000
Total liabilities
31,017,000
Shareholders' equity
171,490,000
Cash and equivalents
20,065,000
Current ratio
8.30

Cash flow and ratios

Operating cash flow
-34,410,000
Free cash flow
-36,178,000

Shareholder returns

Shares outstanding
103,250,292
Book value per share
1.66
Revenue and net income
From revenue to profit 2025
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
Rockville, MD
Exchange
NASDAQ
Fiscal year end
12-31
Industry (SEC)
Services-Commercial Physical & Biological Research

Fiscal year end: · Source: SEC EDGAR

MaxCyte, Inc. trades on NASDAQ under the ticker symbol MXCT. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis